Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.063 CHF | -0.94% | +7.14% | +53.66% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SPEXIS AG | Biopharmaceuticals | -0.94% | +7.14% | +53.66% | -84.05% | - | 4.69M |
- Stock Market
- Equities
- SPEX Stock
- Charts Spexis AG
- Relative Strength Chart